Randomized Trialhigh evidence
Efficacy and safety of the low-temperature-derived 3D printed biodegradable Mg-containing composite porous scaffold for bone defect repair: A prospective and multi-center randomized controlled trial.
Biomaterials·April 1, 2026·PMID 41106318
Why it mattersCritical-size bone defects remain challenging to treat. This first RCT on a low-temperature 3D-printed Mg-containing scaffold demonstrates accelerated early bone fusion and progressive scaffold integration, offering a potential new option for enhancing bone regeneration.

The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled